The analysis of CA125 levels and transvaginal ultrasound in approximately 70,000 ovarian cancer patients showed that these methods had no impact on mortality rates; these findings should eliminate unnecessary surgeries due to false-positives [166]. This evidence concerns the gene MUC16 and ovarian carcinoma.